Cargando…

Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis

IgA vasculitis is the most common systemic small vasculitis in children. Its major clinical manifestations are palpable purpura, arthritis and arthralgias, gastrointestinal involvement, and renal manifestations. Regarding gastrointestinal manifestations, steroids are effective in reducing abdominal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Riko, Oguri, Masato, Tsubata, Shinichi, Adachi, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090550/
https://www.ncbi.nlm.nih.gov/pubmed/35611217
http://dx.doi.org/10.31662/jmaj.2021-0173
_version_ 1784704748716294144
author Kato, Riko
Oguri, Masato
Tsubata, Shinichi
Adachi, Yuichi
author_facet Kato, Riko
Oguri, Masato
Tsubata, Shinichi
Adachi, Yuichi
author_sort Kato, Riko
collection PubMed
description IgA vasculitis is the most common systemic small vasculitis in children. Its major clinical manifestations are palpable purpura, arthritis and arthralgias, gastrointestinal involvement, and renal manifestations. Regarding gastrointestinal manifestations, steroids are effective in reducing abdominal pain. However, exacerbation of gastrointestinal manifestation is frequently experienced when the steroid dose is being tapered. Thus, reliable biomarkers for gastrointestinal mucosal inflammation are needed. We report the case of a 4-year-old girl with abdominal-type IgA vasculitis. During the clinical course, we used several markers, such as fecal immunochemical test, fecal α(1)-antitrypsin and calprotectin. When fecal immunochemical test showed negative results and fecal α(1)-antitrypsin value returned to the normal range, corresponding to her abdominal pain improvement, fecal calprotectin levels remained high. This suggests that fecal calprotectin is more sensitive for evaluating mucosal inflammation than other markers. It could be a useful marker for mucosal inflammation in IgA vasculitis.
format Online
Article
Text
id pubmed-9090550
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japan Medical Association
record_format MEDLINE/PubMed
spelling pubmed-90905502022-05-23 Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis Kato, Riko Oguri, Masato Tsubata, Shinichi Adachi, Yuichi JMA J Case Report IgA vasculitis is the most common systemic small vasculitis in children. Its major clinical manifestations are palpable purpura, arthritis and arthralgias, gastrointestinal involvement, and renal manifestations. Regarding gastrointestinal manifestations, steroids are effective in reducing abdominal pain. However, exacerbation of gastrointestinal manifestation is frequently experienced when the steroid dose is being tapered. Thus, reliable biomarkers for gastrointestinal mucosal inflammation are needed. We report the case of a 4-year-old girl with abdominal-type IgA vasculitis. During the clinical course, we used several markers, such as fecal immunochemical test, fecal α(1)-antitrypsin and calprotectin. When fecal immunochemical test showed negative results and fecal α(1)-antitrypsin value returned to the normal range, corresponding to her abdominal pain improvement, fecal calprotectin levels remained high. This suggests that fecal calprotectin is more sensitive for evaluating mucosal inflammation than other markers. It could be a useful marker for mucosal inflammation in IgA vasculitis. Japan Medical Association 2022-03-25 2022-04-15 /pmc/articles/PMC9090550/ /pubmed/35611217 http://dx.doi.org/10.31662/jmaj.2021-0173 Text en Copyright © Japan Medical Association https://creativecommons.org/licenses/by/4.0/JMA Journal is an Open Access journal distributed under the Creative Commons Attribution 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Case Report
Kato, Riko
Oguri, Masato
Tsubata, Shinichi
Adachi, Yuichi
Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title_full Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title_fullStr Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title_full_unstemmed Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title_short Clinical Significance of Fecal Calprotectin for Evaluating Mucosal Inflammation with IgA Vasculitis
title_sort clinical significance of fecal calprotectin for evaluating mucosal inflammation with iga vasculitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090550/
https://www.ncbi.nlm.nih.gov/pubmed/35611217
http://dx.doi.org/10.31662/jmaj.2021-0173
work_keys_str_mv AT katoriko clinicalsignificanceoffecalcalprotectinforevaluatingmucosalinflammationwithigavasculitis
AT ogurimasato clinicalsignificanceoffecalcalprotectinforevaluatingmucosalinflammationwithigavasculitis
AT tsubatashinichi clinicalsignificanceoffecalcalprotectinforevaluatingmucosalinflammationwithigavasculitis
AT adachiyuichi clinicalsignificanceoffecalcalprotectinforevaluatingmucosalinflammationwithigavasculitis